Novel Coronavirus (SARS-CoV-2/COVID-19)

The Substance Abuse and Mental Health Services Administration today issued an advisory offering evidence-based resources to help clinicians assess and treat mental health symptoms and conditions associated with Long COVID, from fatigue and sleep disturbances to depression, anxiety and post-…
The first data on the safety of a third mRNA COVID-19 vaccine dose among young children show that a third dose is safe for children ages 6 months to 5 years old, similar to findings for doses one and two.
The Food and Drug Administration authorized for marketing the first at-home over-the-counter test for COVID-19 using a traditional premarket review pathway rather than emergency use authorities.
New research from the Center for Disease Control and Prevention indicates that by early fall 2022, an overwhelming percentage of American adults had antibodies to SARS-CoV-2, the virus that causes COVID-19.
The Centers for Medicare & Medicaid Services (CMS) May 31 released a final rule to better align certain regulatory requirements with the end of the public health emergency (PHE), including rescission of the health care worker vaccine mandate.
The Centers for Medicare and Medicaid Services released a FAQ regarding Consolidated Appropriations Act changes for states redetermining Medicaid enrollee eligibility due to the March 31 end of the COVID-19 pandemic’s continuous enrollment requirement.
Accurate coding is critical: AHA's ICD-10-CM FAQs address pneumonia icd10 & dizziness icd10 for precise COVID-19 documentation.
The Department of Health and Human Services yesterday released a fact sheet reviewing how the May 11 end of the COVID-19 public health emergency will affect the flexibilities the declaration enabled.
The Centers for Disease Control and Prevention (CDC) May 8 updated its COVID-19 infection control and prevention guidelines.
After the COVID-19 public health emergency ends on May 11, the Centers for Disease Control and Prevention will use COVID-19-associated hospital admission levels as the primary indicator to guide community and personal decisions related to risk and prevention behaviors.